4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-004385
Director bought 14,500 shares at an average $1.24 ($17,955)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powell Andrew Kenneth William Director | 2024-03-01 | Purchase | +8,500 | $1.23 | $10,455 | 22,863 | D |
| Powell Andrew Kenneth William Director | 2024-03-04 | Purchase | +6,000 | $1.25 | $7,500 | 28,863 | D |
| Open-market purchases · 14,500 sh · avg $1.24 · $17,955 | |||||||
Loading xslF345X05/doc4.xml…